Anticipating a 35% CAGR in 2025, Hims & Hers is poised for substantial growth. Read why I maintain my strong buy rating on ...

Dr. Christopher McGowan, MD, an obesity medicine specialist at True You Weight Loss, says the decision to drink on Ozempic is ...

In real-world settings multiple factors contribute to non-persistence, including adverse effects, high cost-sharing and ...

A collaborative study between Oklahoma State University and the University of Oklahoma is testing whether drugs like Ozempic ...

Health experts are now looking at whether semaglutide can also curb alcohol cravings among addicts. A look at how this GLP-1 category drug functions in humans.

Under the new cooperation deal, Recipharm gets access to Exela’s manufacturing plant in Lenoir, North Carolina. Exela is ...

I highlight potential of Biomea Fusion's diabetes drug amid competition, advises caution with stock due to risks. Read more ...

Munich, Germany, October 1, 2024 – (Euronext Amsterdam: VVY; NL00150002Q7) (Vivoryon), a clinical stage company focused on the discovery and development of small molecule medicines to modulate the ...

The site is extending into producing highly targeted biopharmaceutical drugs, such as antibody drug conjugates (ADCs ... our capabilities in the production of sterile products, such as GLP1, peptides, ...

A once-weekly injectable form of the drug is sold as Wegovy and has also ... 46 weeks of treatment with their dual glucagon/GLP1 agonist survodutide (BI 456906) given as a weekly subcutaneous ...

Combining Popular Diabetes Drugs Offers Complementary Heart and Kidney ... and glucagon-like peptide-1 receptor agonists (GLP1-RAs) is likely to offer additional protection against heart ...